EMA and HealthCanada’s label extension applications are based on positive six-month adolescent Phase 3 data which the Company reported in May 2024 5. These data showed that a single-dose ...
Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that Health Canada has approved the CardioFlux Magnetocardiograph with a license for use by physicians to aid in ...